Article thumbnail

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016

By A. Antinori, A. Di Biagio, S. Marcotullio, M. Andreoni, A. Chirianni, A. d&apos, M. Galli, F. Mazzotta, C. Mussini, M. Puoti and A. Lazzarin

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines

Topics: Guidelines, HIV, Italy, antiretroviral agents, Anti-HIV Agents, Drug Administration Schedule, Drug Therapy, Combination, HIV Infections, Health Policy, Italy, HIV-1, Practice Guidelines as Topic, Settore MED/07 - Microbiologia e Microbiologia Clinica
Publisher: Ponzio
Year: 2017
OAI identifier: oai:air.unimi.it:2434/623249

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.